We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRHM
5726
DELISTED
CRH Medical Corporation
CRHM
$79K ﹤0.01%
25,834
-2,248
-8% -$7.41K
GCAP
5727
DELISTED
Gain Capital Holdings, Inc.
GCAP
$79K ﹤0.01%
12,775
+5,187
+68% +$37.7K
WIN
5728
DELISTED
Windstream Holdings Inc
WIN
$79K ﹤0.01%
37,698
-424,292
-92% -$1.58M
BANX
5729
ArrowMark Financial
BANX
$198M
$78K ﹤0.01%
4,039
+1,878
+87% +$38.7K
BIS icon
5730
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.18M
$78K ﹤0.01%
421
+117
+38% +$18.9K
EPRT icon
5731
Essential Properties Realty Trust
EPRT
$6.63B
$78K ﹤0.01%
5,625
-3,707
-40% -$51.5K
GYRE icon
5732
Gyre Therapeutics
GYRE
$711M
$78K ﹤0.01%
1,312
+173
+15% +$12.8K
OFLX icon
5733
Omega Flex
OFLX
$312M
$78K ﹤0.01%
1,438
-3
-0.2% -$178
USLM icon
5734
United States Lime & Minerals
USLM
$3.33B
$78K ﹤0.01%
5,490
-1,480
-21% -$22.1K
TLND
5735
DELISTED
Talend S.A. American Depositary Shares
TLND
$78K ﹤0.01%
2,087
-2,635
-56% -$127K
SHOS
5736
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$78K ﹤0.01%
36,714
+35,341
+2,574% +$83.9K
MSL
5737
DELISTED
Midsouth Bancorp, Inc.
MSL
$78K ﹤0.01%
7,399
+2,900
+64% +$38.2K
CBPO
5738
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$78K ﹤0.01%
1,016
+929
+1,068% +$68.4K
COOP
5739
DELISTED
Mr. Cooper
COOP
$77K ﹤0.01%
6,627
+3,899
+143% +$55.7K
CVGI icon
5740
Commercial Vehicle Group
CVGI
$155M
$77K ﹤0.01%
13,503
+4,978
+58% +$34.5K
FMAT icon
5741
Fidelity MSCI Materials Index ETF
FMAT
$603M
$77K ﹤0.01%
2,698
FSFG
5742
DELISTED
First Savings Financial Group
FSFG
$77K ﹤0.01%
4,443
+2,940
+196% +$59.1K
TIPT icon
5743
Tiptree Inc
TIPT
$665M
$77K ﹤0.01%
13,876
+6,485
+88% +$37.2K
SMMF
5744
DELISTED
Summit Financial Group, Inc.
SMMF
$77K ﹤0.01%
3,977
+991
+33% +$20.8K
TCFC
5745
DELISTED
The Community Financial Corporation Common Stock
TCFC
$77K ﹤0.01%
2,630
+1,287
+96% +$39.5K
JEMD
5746
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
$77K ﹤0.01%
10,044
+7,522
+298% +$58.2K
CBL
5747
CALL
DELISTED
CBL& Associates Properties, Inc.
CBL
$77K ﹤0.01%
40,100
+18,600
+87% +$54.5K
EMES
5748
PUT
DELISTED
Emerge Energy Services LP
EMES
$77K ﹤0.01%
+50,000
New +$135K
HFXE
5749
DELISTED
IQ 50 Percent Hedged FTSE Europe ETF
HFXE
$77K ﹤0.01%
4,540
+1,227
+37% +$22.4K
AOSL icon
5750
Alpha and Omega Semiconductor
AOSL
$1.01B
$76K ﹤0.01%
7,487
-64
-0.8% -$659

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.